Related Experiment Video
Updated: Jul 22, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas
Zhiwei Qiu1,2, Xiaocong Pang1,2, Qian Xiang1,2
1Department of Pharmacy , Peking University First Hospital, Beijing , China.
Insights
Kidney disease and blood clotting significantly influence each other, posing risks like thrombosis and bleeding in patients. Further research is needed to understand kidney effects on coagulation and develop targeted therapies for nephropathy.
Area of Science:
- Nephrology and Hematology
- Investigating the intricate relationship between renal function and hemostasis.
Background:
- Kidney diseases, including nephrotic syndrome, chronic kidney disease (CKD), and end-stage kidney disease (ESKD), are associated with significant risks of thrombosis and bleeding.
- Current anticoagulant and procoagulant therapies can lead to adverse effects like anticoagulation-related nephropathy and heparin-induced thrombocytopenia, complicating patient prognosis.
Approach:
- Systematic review of existing research on the bidirectional interaction between the coagulation system and kidney diseases.
- Analysis of the current understanding of how the kidney influences coagulation, highlighting areas needing further investigation.
- Evaluation of clinical treatments for coagulation disorders in nephropathy and vice versa.
Key Points:
- The kidney's extensive vasculature makes it susceptible to coagulation disturbances, impacting overall kidney health.
- While some therapeutic targets show promise, their efficacy in nephropathy requires more extensive study.
- Understanding the kidney's role in coagulation is crucial for managing complications in kidney disease patients.
Conclusions:
- The interplay between kidney disease and coagulation is complex, presenting significant clinical challenges.
- Further research into the kidney's effects on coagulation is essential for developing effective therapeutic strategies.
- This review provides insights for future research and clinical guidance in managing coagulation disorders in nephropathy.
Abstract:
The interaction between the kidney and the coagulation system greatly affects each other because of the abundant vessel distribution and blood perfusion in the kidney. Clinically, the risks of complicated thrombosis and bleeding have become important concerns in the treatment of nephropathies, especially nephrotic syndrome, CKD, ESKD, and patients with nephropathy undergoing RRTs. Adverse effects of anticoagulant or procoagulant therapies in patients with nephropathy, especially anticoagulation-related nephropathy, heparin-induced thrombocytopenia, and bleeding, seriously worsen the prognosis of patients, which have become challenges for clinicians. Over the decades, the interaction between the kidney and the coagulation system has been widely studied. However, the effects of the kidney on the coagulation system have not been systematically investigated. Although some coagulation-related proteins and signaling pathways have been shown to improve coagulation abnormalities while avoiding additional kidney damage in certain kidney diseases, their potential as anticoagulation targets in nephropathy requires further investigation. Here, we review the progression of research on the crosstalk between the coagulation system and kidney diseases and systematically analyze the significance and shortcomings of previous studies to provide new sight into future research. In addition, we highlight the status of clinical treatment for coagulation disorder and nephropathy caused by each other, indicating guidance for the formulation of therapeutic strategies or drug development.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations

